• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病发病率登记的试验仿真与生存分析:以抢先性肾移植的因果效应为例

Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre-emptive kidney transplantation.

机构信息

Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academisch Medisch Centrum, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Stat Med. 2022 Sep 20;41(21):4176-4199. doi: 10.1002/sim.9503. Epub 2022 Jul 9.

DOI:10.1002/sim.9503
PMID:35808992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9543809/
Abstract

When drawing causal inference from observed data, failure time outcomes present additional challenges of censoring often combined with other missing data patterns. In this article, we follow incident cases of end-stage renal disease to examine the effect on all-cause mortality of starting treatment with transplant, so-called pre-emptive kidney transplantation, vs starting with dialysis possibly followed by delayed transplantation. The question is relatively simple: which start-off treatment is expected to bring the best survival for a target population? To address it, we emulate a target trial drawing on the long term Swedish Renal Registry, where a growing common set of baseline covariates was measured nationwide. Several lessons are learned which pertain to long term disease registers more generally. With characteristics of cases and versions of treatment evolving over time, informative censoring is already introduced in unadjusted Kaplan-Meier curves. This leads to misrepresented survival chances in observed treatment groups. The resulting biased treatment association may be aggravated upon implementing IPW for treatment. Aware of additional challenges, we further recall how similar studies to date have selected patients into treatment groups based on events occurring post treatment initiation. Our study reveals the dramatic impact of resulting immortal time bias combined with other typical features of long-term incident disease registers, including missing covariates during the early phases of the register. We discuss feasible ways of accommodating these features when targeting relevant estimands, and demonstrate how more than one causal question can be answered relying on the no unmeasured baseline confounders assumption.

摘要

当从观察数据中得出因果推论时,失效时间结果通常会伴随着其他缺失数据模式的删失,这带来了额外的挑战。在本文中,我们以终末期肾病的发病病例为研究对象,考察了以移植(所谓的抢先性肾移植)作为起始治疗方案与以透析起始,可能随后延迟移植的方案相比,对全因死亡率的影响。问题相对简单:对于目标人群,哪种起始治疗方案预期会带来最佳生存?为了解决这个问题,我们模仿了一项基于长期瑞典肾脏登记的目标试验,该登记在全国范围内测量了越来越多的共同基线协变量。我们总结了一些更普遍适用于长期疾病登记的经验教训。随着病例特征和治疗版本随时间的演变,未调整的 Kaplan-Meier 曲线中已经引入了信息性删失。这导致观察治疗组中的生存机会被错误代表。在实施基于倾向评分的治疗时,这种偏倚的治疗关联可能会加剧。鉴于额外的挑战,我们进一步回忆起迄今为止,类似的研究如何根据治疗开始后发生的事件将患者选入治疗组。我们的研究揭示了由此产生的不朽时间偏倚与长期发病疾病登记的其他典型特征相结合的巨大影响,包括登记早期阶段缺失的协变量。我们讨论了在针对相关估计量时适应这些特征的可行方法,并展示了如何依靠无未测量的基线混杂因素假设回答多个因果问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/1f436842c927/SIM-41-4176-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/28a92eec096a/SIM-41-4176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/762157f1c409/SIM-41-4176-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/9670240263d1/SIM-41-4176-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/8fc9505d7155/SIM-41-4176-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/8a7fb928a251/SIM-41-4176-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/57be6a096638/SIM-41-4176-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/4988c2ac3c23/SIM-41-4176-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/f668f435a4f8/SIM-41-4176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/7c7362aae3d3/SIM-41-4176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/1f436842c927/SIM-41-4176-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/28a92eec096a/SIM-41-4176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/762157f1c409/SIM-41-4176-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/9670240263d1/SIM-41-4176-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/8fc9505d7155/SIM-41-4176-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/8a7fb928a251/SIM-41-4176-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/57be6a096638/SIM-41-4176-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/4988c2ac3c23/SIM-41-4176-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/f668f435a4f8/SIM-41-4176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/7c7362aae3d3/SIM-41-4176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3279/9543809/1f436842c927/SIM-41-4176-g009.jpg

相似文献

1
Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre-emptive kidney transplantation.疾病发病率登记的试验仿真与生存分析:以抢先性肾移植的因果效应为例
Stat Med. 2022 Sep 20;41(21):4176-4199. doi: 10.1002/sim.9503. Epub 2022 Jul 9.
2
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
3
Dialysis vintage and outcomes in renal transplantation.透析使用年限与肾移植的结局。
Nephrol Dial Transplant. 2019 Apr 1;34(4):555-560. doi: 10.1093/ndt/gfy099.
4
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
5
The survival benefit of kidney transplantation in the setting of combined peripheral arterial disease and end-stage renal failure.在合并外周动脉疾病和终末期肾衰竭情况下肾移植的生存获益。
Clin Transplant. 2016 May;30(5):545-55. doi: 10.1111/ctr.12720. Epub 2016 Mar 11.
6
UK Renal Registry 11th Annual Report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses.英国肾脏注册机构第11次年度报告(2008年12月):第7章2007年接受肾脏替代治疗的英国成年患者的生存率及死亡原因:全国性和特定中心分析
Nephron Clin Pract. 2009;111 Suppl 1:c113-39. doi: 10.1159/000209996. Epub 2009 Mar 26.
7
Duration of end-stage renal disease and kidney transplant outcome.终末期肾病的病程与肾移植结果。
Nephrol Dial Transplant. 2005 Jan;20(1):167-75. doi: 10.1093/ndt/gfh541. Epub 2004 Nov 16.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
[Access to the waiting list and renal transplantation].[进入等待名单与肾移植]
Nephrol Ther. 2013 Sep;9 Suppl 1:S139-66. doi: 10.1016/S1769-7255(13)70043-9.
10
Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes.美国非优先活体供肾移植前透析暴露的差异及其与移植物结局的关系。
Am J Kidney Dis. 2018 May;71(5):636-647. doi: 10.1053/j.ajkd.2017.11.012. Epub 2018 Feb 1.

引用本文的文献

1
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review.旨在模拟随机试验的观察性研究报告:系统评价。
JAMA Netw Open. 2023 Sep 5;6(9):e2336023. doi: 10.1001/jamanetworkopen.2023.36023.

本文引用的文献

1
Formulating causal questions and principled statistical answers.提出因果问题并给出有原则的统计答案。
Stat Med. 2020 Dec 30;39(30):4922-4948. doi: 10.1002/sim.8741. Epub 2020 Sep 23.
2
Empirical use of causal inference methods to evaluate survival differences in a real-world registry vs those found in randomized clinical trials.在真实世界的注册研究中,运用因果推断方法评估生存差异的实证研究,与随机临床试验中的结果存在差异。
Stat Med. 2020 Sep 30;39(22):3003-3021. doi: 10.1002/sim.8581. Epub 2020 Jul 9.
3
Extending inferences from a randomized trial to a new target population.
将随机试验的推断扩展到新的目标人群。
Stat Med. 2020 Jun 30;39(14):1999-2014. doi: 10.1002/sim.8426. Epub 2020 Apr 6.
4
Temporal recalibration for improving prognostic model development and risk predictions in settings where survival is improving over time.用于在生存随时间改善的情况下改进预后模型开发和风险预测的时间重新校准。
Int J Epidemiol. 2020 Aug 1;49(4):1316-1325. doi: 10.1093/ije/dyaa030.
5
Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding.改进的两阶段估计法以调整随机试验中的治疗转换:用于解决时间依存性混杂的g估计法。
Stat Methods Med Res. 2020 Oct;29(10):2900-2918. doi: 10.1177/0962280220912524. Epub 2020 Mar 30.
6
Doubly robust tests of exposure effects under high-dimensional confounding.高维混杂下暴露效应的双稳健检验。
Biometrics. 2020 Dec;76(4):1190-1200. doi: 10.1111/biom.13231. Epub 2020 Feb 28.
7
The impact of childhood cancer on parental working status and income in Denmark: Patterns over time and determinants of adverse changes.丹麦儿童癌症对父母工作状况和收入的影响:随时间变化的模式及不利变化的决定因素。
Int J Cancer. 2020 Aug 15;147(4):1006-1017. doi: 10.1002/ijc.32867. Epub 2020 Jan 31.
8
A novel approach for identifying and addressing case-mix heterogeneity in individual participant data meta-analysis.一种用于在个体参与者数据荟萃分析中识别和处理病例组合异质性的新方法。
Res Synth Methods. 2019 Dec;10(4):582-596. doi: 10.1002/jrsm.1382. Epub 2019 Dec 2.
9
Covariate-adjusted survival analyses in propensity-score matched samples: Imputing potential time-to-event outcomes.倾向得分匹配样本中的协变量调整生存分析:估算潜在的事件发生时间结局。
Stat Methods Med Res. 2020 Mar;29(3):728-751. doi: 10.1177/0962280218817926. Epub 2018 Dec 20.
10
Estimating the causal effect of treatment regimes for organ transplantation.估计器官移植治疗方案的因果效应。
Biometrics. 2018 Dec;74(4):1407-1416. doi: 10.1111/biom.12921. Epub 2018 Jul 10.